How Manufacturing PE Roll-Ups Work in 2026: Multiple Arbitrage, Integration Playbook, and Named Platforms

If you own a U.S. manufacturing business and a PE firm has reached out about a roll-up, the question isn’t whether they’re a real buyer — they almost certainly are. The question is what role you play in their roll-up: platform anchor or add-on bolt-on. The answer dictates the multiple you receive, the deal structure, the rollover equity terms, and your post-close role. Platforms get 6-9x EBITDA with 20-30% rollover equity and CEO continuity. Add-ons get 4-6x EBITDA with 10-20% rollover and integration into existing platform infrastructure. Same buyer firm, materially different terms.

This guide explains how manufacturing PE roll-ups actually work in 2026. We’ll walk through platform vs add-on mechanics, the multiple arbitrage math (why a 7x platform + 5x add-ons exiting at 8.5x produces $20-40M of value creation before operational synergies), the manufacturing-specific synergies (capacity utilization, customer cross-sell, supply chain consolidation, equipment redundancy elimination), the integration playbook used by named platforms (Audax Industrial, GenNx360 Capital, Trive Capital, Sterling Group, Wynnchurch Capital, Cortec Group, Industrial Growth Partners, AE Industrial Partners, Liberty Hall Capital, Linden Capital Partners, Patient Square Capital, Arsenal Capital Partners, Wind Point Partners), and the common failure modes that destroy roll-up value (cultural integration, equipment redundancy, customer concentration overlap, workforce integration, failed certifications).

The framework draws on direct work with 76+ active U.S. lower middle market buyers, of which 38 maintain explicit manufacturing or industrial mandates including platform builders and active add-on programs. We’re a buy-side partner. The buyers pay us when a deal closes — not you. That includes generalist industrial PE platforms running active roll-ups (Audax Industrial, GenNx360, Trive Capital, Sterling Group, Wynnchurch Capital, Cortec Group, IGP, Mason Wells, Pfingsten Partners, AEA Investors, Genstar Capital, Pamlico Capital), sub-vertical specialist roll-ups (AE Industrial Partners and Liberty Hall Capital in aerospace, Linden Capital Partners and Patient Square Capital and LaSalle Capital in medical device, Arsenal Capital Partners in industrial chemicals, Wind Point Partners in consumer/industrial), public-company consolidators effectively running their own roll-ups (APi Group on NYSE: APG, Comfort Systems USA on NYSE: FIX, Watsco on NYSE: WSO, Roper Technologies on NYSE: ROP, HEICO on NYSE: HEI, Atkore on NYSE: ATKR, Curtiss-Wright on NYSE: CW, TransDigm on NYSE: TDG, Harsco on NYSE: HSC, Ametek on NYSE: AME), and mega-fund industrial verticals (KKR Industrials, Carlyle industrials, Bain Capital industrials, Onex Partners industrials, Bromford Industries) at platform-of-platform scale. The point of this article isn’t to convince you to sell — it’s to give you a transparent view of how manufacturing roll-ups actually work so you can negotiate from a position of understanding.

One realistic note before you start. Roll-up economics work for PE firms regardless of operational performance. The multiple arbitrage between a 5x add-on cost basis and an 8.5x exit multiple delivers value creation even if EBITDA stays flat. That’s why the named platforms above pursue manufacturing roll-ups so aggressively — the model is structurally profitable. As a seller, you can capture more of that value by understanding the math and negotiating accordingly.

“Manufacturing roll-ups are economically irresistible to PE because the math works regardless of operational performance. A 7x platform plus 5x add-ons exiting at 8.5x produces multiple arbitrage of $20-40M on a $50-100M cumulative deployment — before any operational synergies. The named platforms doing this volume in 2026 (Audax Industrial, GenNx360 Capital, Trive Capital, Sterling Group, Wynnchurch Capital, AE Industrial Partners, Linden Capital Partners) have refined the playbook over multiple cycles. Sellers who understand the math negotiate better deals; sellers who don’t, leave 1-3x EBITDA on the table.”

Key Takeaways

• Manufacturing roll-ups create value through three mechanisms: multiple arbitrage (4-5x add-on cost basis vs 8.5x platform exit multiple), operational synergies (capacity utilization, customer cross-sell, supply chain consolidation), and platform scaling (organic growth + EBITDA margin expansion).
• Platform vs add-on math: PE platform buys at 6-9x EBITDA at $5M-$30M EBITDA scale. Add-ons bolt on at 4-6x at $1M-$5M EBITDA scale. Blended cost basis of platform + add-ons typically 5.5-6.5x EBITDA. Exit at 8-9x EBITDA produces 2-3x of multiple arbitrage on add-ons.
• Manufacturing-specific synergies: capacity utilization (200-400 bps EBITDA margin expansion), customer cross-sell (8-15% organic revenue), supply chain consolidation (100-300 bps), equipment redundancy elimination (50-150 bps + one-time cash).
• Named platforms heavy in 2026 manufacturing roll-ups: Audax Industrial, GenNx360, Trive Capital, Sterling Group, Wynnchurch Capital, Cortec Group, IGP, Mason Wells, Pfingsten Partners, AEA Investors, Genstar Capital, Pamlico Capital. Sub-vertical specialists: AE Industrial Partners, Liberty Hall Capital, Linden Capital Partners, Patient Square Capital, LaSalle Capital, Arsenal Capital, Wind Point Partners.
• Common roll-up failures: cultural integration (30-40%), equipment redundancy (15-25%), customer concentration overlap (10-15%), workforce integration (10-15%), failed certifications (5-10%). Knowing failure modes helps sellers structure protective deal terms.
• Sellers can capture more roll-up value through: rollover equity (20-30% participation in platform exit), earn-up payments tied to platform performance, board observer rights, and clear integration commitments protecting employees and customers.

The structural economics of manufacturing PE roll-ups

Manufacturing PE roll-ups exist because three structural forces make consolidation economically attractive. First, U.S. manufacturing is highly fragmented — thousands of $1M-$10M EBITDA family-owned shops across most sub-verticals (machining, fabrication, plastic injection, contract manufacturing, specialty manufacturing). Second, baby-boomer ownership demographics — the NTMA, AMT, and PMA membership surveys document that 60%+ of U.S. manufacturing owner-CEOs are above age 60. Third, capex-intensive operations create scale advantages: combined purchasing, equipment utilization, customer relationships, and certifications scale better than they replicate.

The PE roll-up math. PE platforms underwrite manufacturing roll-ups around a multiple arbitrage thesis. Buy a platform at 7x EBITDA. Bolt on three to seven add-ons at 4-6x EBITDA each (smaller bolt-ons cheaper per dollar of EBITDA). Hold for 3-5 years through organic growth + integration synergies. Exit at 8-9x EBITDA to a larger PE buyer (mega-fund industrial vertical) or public-company strategic. Multiple arbitrage between blended-cost-basis multiple and exit multiple drives 2-3x of value creation, before any operational synergies.

Worked example: a $5M EBITDA precision machining roll-up. Platform: PE firm buys $5M EBITDA precision machining business at 7x = $35M TEV. Add-on 1: $2M EBITDA bolt-on at 5x = $10M TEV. Add-on 2: $1.5M EBITDA bolt-on at 5x = $7.5M TEV. Add-on 3: $2.5M EBITDA bolt-on at 5x = $12.5M TEV. Combined deployment: $11M EBITDA at $65M TEV = 5.9x blended cost basis. After 4 years of organic growth (8% CAGR + 200 bps margin expansion from synergies), platform reaches $14.5M EBITDA. Exit at 8.5x = $123M TEV. Value created: $123M – $65M = $58M, of which $28.5M is multiple arbitrage and $29.5M is EBITDA growth contribution at exit multiple.

Why PE pays add-on prices below platform prices. Add-ons trade at lower multiples (4-6x vs 6-9x) because: (1) bolt-ons don’t need standalone management — the platform team integrates and operates them, eliminating the management premium; (2) integration cost is real ($500K-$2M per add-on in IT systems, ERP integration, certification audits, severance for redundant roles); (3) bolt-ons benefit from immediate multiple arbitrage at the platform’s exit, which the platform captures rather than the add-on seller; (4) the buyer pool for sub-$5M EBITDA businesses is genuinely smaller, supporting lower multiples.

Platform vs add-on: which is your business?

Platform investments are the foundation of a roll-up. PE platforms target $5M-$30M EBITDA businesses with: documented operational systems (MES/ERP integration, monthly closes within 15 days, CPA-prepared financials), real management depth (CFO, COO, head of operations or sales), sub-vertical specialization or growth runway, manageable customer concentration (top 5 under 50% ideally, top 1 under 30%), and capex profile that supports growth (3-6% of revenue ongoing capex). Platform investments price at 6-9x TEV/EBITDA with 20-30% rollover equity, 12-24 month earnout, and CEO continuity for 2-4 years.

Add-on investments bolt onto existing platforms. PE add-ons target $1M-$5M EBITDA businesses with: customer book that complements the platform (geography, end-market, technical capability), capacity that platform can absorb, key technical talent retainable post-close, certifications the platform doesn’t have, and willingness to integrate. Add-ons price at 4-6x EBITDA with 10-20% rollover, retention-focused earnouts, and key-employee retention plans (rather than CEO continuity).

How to identify which role you fit. EBITDA size: under $5M = realistically add-on; $5M-$30M = either platform or add-on depending on platform fit; $30M+ = platform or platform-of-platform. Management depth: CFO/COO present = platform-eligible; owner-only = add-on. Operational systems: documented MES/ERP, monthly closes, CPA financials = platform; informal systems = add-on. Sub-vertical match: if you’re the first acquisition into a sub-vertical, platform; if there’s already a platform in your sub-vertical, add-on.

Why this matters for negotiation. If you’re a platform-quality business getting add-on prices (4-6x), you’re leaving 1-3x EBITDA on the table. If you’re positioned as platform but the buyer concludes you’re actually add-on-quality (no real management depth, weak systems), they re-trade you to add-on pricing during diligence. The pre-LOI positioning — financial reporting, organizational structure, operational systems — determines whether your business gets platform or add-on treatment.

The multiple arbitrage math: how PE earns its return

Multiple arbitrage is the single largest value-creation driver in manufacturing roll-ups. PE platforms enter at platform multiples (6-9x), bolt on add-ons at lower multiples (4-6x), blend down the cost basis, then exit at platform multiples or higher (8-9x typically, sometimes 10-12x for sub-vertical specialty). Even with zero EBITDA growth, the multiple arbitrage delivers 1.5-2.5x return on invested capital.

Why exit multiples expand over hold period. Several factors drive exit multiple expansion: (1) larger platforms ($20M+ EBITDA at exit) sell to mega-fund industrial verticals (KKR Industrials, Carlyle industrials, Bain Capital industrials, Onex Partners industrials, Bromford Industries) at higher multiples than middle-market platform multiples; (2) management depth, certifications, and operational maturity improve over hold period, justifying multiple expansion; (3) sub-vertical specialization deepens (multiple bolt-ons in same sub-vertical create competitive moat, which justifies higher multiple); (4) recurring/contracted revenue typically increases as a percentage of total revenue through bolt-on integration.

EBITDA growth compounds the multiple arbitrage benefit. On top of multiple arbitrage, organic EBITDA growth (typically 6-12% CAGR for well-managed manufacturing platforms) compounds value creation. A platform that grows EBITDA from $11M to $14.5M over 4 years (7% CAGR) and exits at 8.5x produces $58M of cumulative value vs $35M-$45M from multiple arbitrage alone. The combination of multiple arbitrage + organic growth + operational synergies typically produces 2.5-3.5x MOIC (multiple on invested capital) for the PE platform.

What this means for sellers negotiating rollover equity. If you roll 25% of equity into a manufacturing platform, you participate in the same multiple arbitrage and EBITDA growth that drives the PE firm’s 2.5-3.5x return. Your rollover equity can return 1.5-2.5x at platform exit, often producing more after-tax proceeds than the cash portion of the original sale. Many sub-vertical specialists (AE Industrial Partners, Liberty Hall Capital, Linden Capital Partners) explicitly structure rollover terms to incentivize long-term founder participation precisely because the multiple arbitrage thesis depends on continued operational excellence.

Manufacturing-specific synergies: where the operational value comes from

Beyond multiple arbitrage, manufacturing roll-ups generate operational synergies that compound returns. Four manufacturing-specific synergy categories drive most of the operational value: capacity utilization, customer cross-sell, supply chain consolidation, and equipment redundancy elimination. Each requires real integration work and takes 12-36 months to materialize, but cumulatively can add 400-800 bps of EBITDA margin expansion.

Capacity utilization (200-400 bps EBITDA margin expansion). Manufacturing facilities typically operate at 60-85% capacity utilization. Roll-ups consolidate work across acquired facilities to push platform utilization toward 85-95%. Common tactics: route overflow demand from one facility to another with idle capacity, consolidate low-volume work to a single facility while specializing high-volume work elsewhere, eliminate redundant work cells across acquired shops. Margin impact: 200-400 bps over 24-36 months.

Customer cross-sell (8-15% organic revenue uplift). Each acquired add-on brings customer relationships the platform doesn’t have. Cross-selling platform capabilities (e.g., AS9100 aerospace work) to add-on customers (e.g., commercial machining customers wanting to qualify aerospace work) creates organic revenue uplift. Conversely, platform customers gain access to add-on capabilities (e.g., new geographic locations, new technical capabilities). Realistic uplift: 8-15% incremental revenue over 24-36 months.

Supply chain consolidation (100-300 bps margin expansion). Combined purchasing of raw materials (steel, aluminum, plastic resin, specialty alloys), tooling, and consumables across the platform produces 5-15% input cost savings. Vendor consolidation reduces administrative overhead. Centralized purchasing function negotiates better terms than individual shops. Margin impact: 100-300 bps over 12-24 months. Particularly meaningful in metal fabrication, machining, and plastic injection sub-verticals where raw materials are 30-50% of revenue.

Equipment redundancy elimination (50-150 bps margin + one-time cash unlock). Acquired add-ons often have redundant CNC, fabrication, or molding equipment. Selling redundant equipment (often $500K-$5M of book value across 3-5 add-ons) generates one-time cash and reduces ongoing maintenance, depreciation, and floor space costs. Margin impact: 50-150 bps over 24-36 months. Tactically delicate — selling equipment without disrupting customer programs requires careful capacity planning.

Other manufacturing synergies. Centralized engineering function (eliminate redundant engineering across add-ons): 50-150 bps. Centralized quality systems (single AS9100/ISO 13485/ISO 9001 audit instead of 3-5 separate audits): 25-75 bps. ERP consolidation (single MES/ERP across all facilities): 50-150 bps. Combined sales and marketing (single sales team covering all customer relationships): 100-300 bps. Reduced redundant overhead (CFO, HR, IT consolidation across acquired add-ons): 200-400 bps.

The named manufacturing PE platforms running 2026 roll-ups

Generalist industrial PE platforms with active 2026 manufacturing roll-ups. Audax Industrial (~$43B AUM) runs aggressive industrial services and manufacturing roll-ups across multiple sub-verticals. Genstar Capital ($50B+) deploys actively into industrial roll-ups with sub-vertical specialization. AEA Investors ($18B+) runs middle-market industrial and value-added services roll-ups. Trive Capital (~$5B) runs Texas-headquartered industrial roll-ups. Sterling Group ($5B+) runs operations-intensive industrial roll-ups with deep manufacturing focus. Wynnchurch Capital (~$5B) runs middle-market industrial roll-ups. Cortec Group ($2B+) runs specialty manufacturing and industrial roll-ups. GenNx360 Capital (~$1.5B) runs middle-market industrial roll-ups. Industrial Growth Partners (IGP) runs dedicated industrial roll-ups. Mason Wells, Pfingsten Partners, Pamlico Capital ($3B+) all run active manufacturing roll-up programs.

Sub-vertical specialist roll-ups. AE Industrial Partners (~$5B) runs aggressive aerospace and defense roll-ups. Liberty Hall Capital Partners runs aerospace roll-ups. Linden Capital Partners ($8B+) runs medical-device and healthcare manufacturing roll-ups. Patient Square Capital (~$10B) runs medical-device and life-sciences roll-ups. LaSalle Capital runs lower-middle-market medical-device roll-ups. Arsenal Capital Partners ($8B+) runs industrial chemicals and specialty materials roll-ups. Wind Point Partners ($3B+) runs consumer/industrial diversified roll-ups.

Public-company consolidators effectively running their own roll-ups. APi Group (NYSE: APG, ~$7B revenue) is one of the most active public-company industrial-services consolidators, with substantial M&A activity year over year. Comfort Systems USA (NYSE: FIX) runs mechanical-electrical roll-ups. Watsco (NYSE: WSO) runs HVAC distribution consolidation. Roper Technologies (NYSE: ROP) runs niche industrial-software-adjacent roll-ups. HEICO (NYSE: HEI) is the most active public aerospace/defense parts consolidator. Atkore (NYSE: ATKR), Curtiss-Wright (NYSE: CW), TransDigm (NYSE: TDG), Harsco (NYSE: HSC), Ametek (NYSE: AME) all run active manufacturing-adjacent roll-up programs.

Mega-fund industrial verticals at platform-of-platform scale. KKR Industrials, Carlyle industrials, Bain Capital industrials, Onex Partners industrials, and Bromford Industries typically acquire $20M+ EBITDA platforms (often roll-ups themselves at exit from middle-market PE) and run platform-of-platform roll-ups at larger scale. They’re both buyers of middle-market roll-up exits and operators of larger industrial consolidations.

The integration playbook: how named platforms execute roll-ups

Day 1-100 integration. Establish governance structure: platform CEO retains operational control of acquired add-on facility for 90-180 days; PE deal team places financial controls and reporting standards; HR begins payroll/benefits integration. Communication plan: customer notification within 24-72 hours of close; employee notification at close; vendor notification within 30 days. Quick wins identified: low-risk synergy projects (purchasing consolidation for raw materials, eliminating redundant software licenses, consolidating banking relationships) executed in first 100 days.

Months 4-12: financial and operational integration. ERP/MES consolidation begins (typically 9-18 months total). Quality systems consolidate (single AS9100/ISO 13485/ISO 9001 audit instead of multiple). Centralized engineering function established. Customer relationships transferred from acquired-CEO-owned to platform sales structure. Equipment audit identifies redundancy candidates. Capacity utilization plan executed. Organizational consolidation: redundant overhead roles eliminated (CFO, HR, IT roles in acquired add-on typically consolidate to platform, with 12-18 month transition packages).

Months 12-24: synergy realization. Capacity utilization improves toward 85-95% target. Customer cross-sell programs launch and produce 8-15% incremental organic revenue over 24 months. Supply chain consolidation realizes 5-15% raw material cost savings. Equipment sales of redundant assets generate one-time cash. Cultural integration completes (employees identify with platform brand rather than legacy add-on brand). EBITDA margin expansion of 400-800 bps over 24-36 months.

Months 24-48: platform scaling and exit prep. Continued add-on acquisitions if platform thesis supports more bolt-ons. Organic growth investment (sales hiring, geographic expansion, new product development). Platform reaches $20M+ EBITDA scale, opening exit pathways to mega-fund industrial verticals (KKR, Carlyle, Bain Capital, Onex) or public-company consolidators (APi Group, Comfort Systems USA, Watsco, Roper, HEICO, Atkore, Curtiss-Wright, TransDigm, Harsco, Ametek). Exit prep: investment banker hire, CIM development, management presentation refinement, exit auction or proprietary process.

Common manufacturing roll-up failure modes

Cultural integration failures (30-40% of failed integrations). Regional family-owned manufacturing add-ons often resist platform standardization. Long-tenure employees identify with the founder/owner brand rather than the new corporate parent. Quality system standardization, ERP consolidation, and reporting structure changes can trigger turnover among key technical talent. Mitigation: explicit cultural integration plan, retention bonuses for key technical employees (typically 3-5 employees per add-on, $25K-$200K bonuses tied to 12-24 month retention), founder/CEO transition support.

Equipment redundancy and capex consolidation (15-25% of failed integrations). Acquired add-ons often have overlapping CNC, fabrication, or molding equipment. Consolidating to fewer facilities requires careful customer-program transition (which customer’s work runs on which equipment in which location). Failed consolidations create customer disruption, missed deliveries, and lost programs. Mitigation: careful pre-close capacity audit, customer-by-customer transition planning, equipment timing aligned with capacity availability.

Customer concentration overlap (10-15%). Platform and add-on may share top customers, creating portfolio-level customer concentration that buyers (the eventual exit acquirer) discount heavily. A platform with 25% concentration on Customer X and an add-on with 30% concentration on the same Customer X creates 27%+ combined concentration with single-customer exposure. Mitigation: pre-acquisition customer overlap analysis, intentional customer diversification post-close.

Workforce integration (10-15%). Union vs non-union mix, different benefit structures (PTO, health insurance, retirement plans), different wage scales create integration complexity. Forcing union add-on workforce onto non-union platform structure can trigger union grievances, walkouts, or NLRB filings. Mitigation: workforce assessment in pre-close diligence, separate integration paths for unionized and non-union workforces, careful HR transition planning.

Failed certification audits post-integration (5-10%). Platform AS9100, ISO 13485, NADCAP, ITAR, or FDA certifications may fail audit after add-on integration if processes diverge or add-on facility doesn’t meet platform standards. Failed certifications can trigger customer program loss (Tier 1 OEMs require certified suppliers), revenue compression, and re-certification cost ($100K-$500K per certification). Mitigation: pre-close certification gap analysis, integration plan includes certification audit alignment, separate-certification approach during transition if needed.

How sellers can capture more value from manufacturing roll-ups

Tactic 1: rollover equity participation. Rolling 20-30% equity into the platform gives you proportional participation in multiple arbitrage, EBITDA growth, and operational synergies. Sellers who roll often realize 1.5-2.5x of additional after-tax proceeds at platform exit in 3-5 years. Negotiate rollover terms carefully: anti-dilution rights, tag-along/drag-along rights, valuation methodology, vesting schedule, employment agreement linkage.

Tactic 2: earn-up payments tied to platform performance. Standard earnouts tie to your business’s specific performance post-close. Earn-ups go further — tying additional contingent payments to platform-level performance milestones (platform EBITDA, platform revenue, platform exit valuation). Earn-ups capture upside if the roll-up exceeds plan, even if your specific add-on contribution stays flat.

Tactic 3: board observer rights. Board observer rights give you visibility into platform strategy, exit planning, and operational decisions affecting your rollover equity. Important if you roll 25%+ equity and want transparency on the platform’s exit timing and methodology. Negotiate observer rights at LOI rather than at close.

Tactic 4: integration commitments protecting employees and customers. Many manufacturing sellers care deeply about employee continuity and customer relationship continuity. Negotiate explicit integration commitments at LOI: minimum employee retention period (often 12-24 months), retention bonuses for key technical employees, customer notification protocols, facility consolidation timing, brand continuity period. These don’t cost the buyer headline price but provide meaningful seller protection.

Tactic 5: multi-buyer process to validate market multiple. Even if a specific PE platform reaches out with a roll-up offer, run a parallel process with 5-10 thesis-aligned named platforms (sub-vertical specialists where applicable, generalists, and 1-2 strategic acquirers). Multi-buyer processes typically improve headline price by 0.5-1.5x EBITDA and improve deal terms (rollover, earnout, earn-up, retention) substantially. Most sellers who accept the first offer leave 1-2x EBITDA on the table.

Why manufacturing roll-ups are accelerating in 2026

Industrial PE dry powder is at record levels. Combined committed-but-unspent capital across U.S. industrial-focused PE platforms is estimated at $200B+ in 2026. Recent fund vintages (2023-2025) at named platforms (Audax Industrial, Genstar Capital, AEA Investors, Trive Capital, Sterling Group, Wynnchurch Capital, AE Industrial Partners, Linden Capital Partners, Patient Square Capital, Arsenal Capital Partners) have raised record amounts and are deploying actively into manufacturing roll-ups.

Reshoring/nearshoring drives platform thesis demand. U.S. reshoring announcements at multi-year highs through 2024-2026, supply-chain resilience priorities, geopolitical tensions, and elevated PMI/ISM Manufacturing Index readings drive sustained LP allocation to U.S. industrial roll-ups. Specialty PE platforms targeting domestic manufacturing capacity have raised record funds explicitly tied to reshoring theses.

Aging baby-boomer ownership creates seller-side supply. NTMA, AMT, PMA, NAM, MAPI, and Material Handling Institute membership surveys document that 60%+ of U.S. manufacturing owner-CEOs are above age 60. The supply of aging-owner sellers entering market over 2025-2030 supports sustained roll-up activity at the named platforms above. Demographic dynamics are structural, not cyclical.

CHIPS Act, defense modernization, and IIoT drive sub-vertical specialty roll-ups. CHIPS Act semiconductor capex (Samsung Taylor, TI Sherman, Intel Ohio, GlobalFoundries Sherman, TSMC Arizona, Micron Boise) drives semiconductor capital equipment and electronics manufacturing roll-ups. Defense modernization (B-21 Raider, F-35, NGAD, missile defense) drives aerospace/defense roll-ups at AE Industrial Partners, Liberty Hall Capital, HEICO, TransDigm, Curtiss-Wright. IIoT and Industry 4.0 adoption drives industrial automation and digital-manufacturing roll-ups at Roper Technologies and Ametek.

Public consolidators competing with PE for the same deals. Public-company consolidators (APi Group, Comfort Systems USA, Watsco, Roper, HEICO, Atkore, Curtiss-Wright, TransDigm, Harsco, Ametek) increasingly compete with PE platforms for the same target businesses, often at higher headline multiples driven by synergy logic. The competitive bidding dynamic between PE and public strategics creates unusually favorable seller leverage in 2026 manufacturing M&A.

Sub-vertical specific roll-up dynamics across manufacturing

Aerospace/defense roll-ups operate on a longer time horizon and higher multiple base than generalist manufacturing. AE Industrial Partners (~$5B AUM) and Liberty Hall Capital Partners have built aerospace roll-ups by acquiring AS9100-certified, NADCAP-accredited, ITAR-registered platforms at 7-10x EBITDA and bolting on smaller specialty manufacturers at 5-7x. Public consolidator HEICO (NYSE: HEI) has run a multi-decade aerospace/defense parts roll-up paying 8-12x EBITDA for differentiated platforms. TransDigm (NYSE: TDG) and Curtiss-Wright (NYSE: CW) compete in adjacent aerospace/defense roll-ups. The aerospace/defense roll-up cycle typically runs 4-7 years (longer than generalist 3-5 years) because of program-cycle visibility (B-21 Raider, F-35 sustainment, NGAD, CCA cycles) and certification timelines.

Medical device roll-ups operate on the highest multiple base in U.S. manufacturing. Linden Capital Partners ($8B+ AUM) and Patient Square Capital (~$10B AUM) have built medical-device contract manufacturing roll-ups paying 8-12x EBITDA at platform scale. LaSalle Capital (Chicago) covers lower-middle-market medical-device roll-ups at $3M-$15M EBITDA. ISO 13485 + FDA registration is the entry threshold; without certification, businesses don’t enter the medical-device specialist buyer pool. Major medical-device OEMs (Medtronic, Stryker, Johnson & Johnson, Boston Scientific, Abbott, Becton Dickinson) acquire contract manufacturers strategically as well, creating competitive bidding for differentiated medical-device platforms.

Industrial chemicals and specialty materials roll-ups. Arsenal Capital Partners ($8B+ AUM) is the leading dedicated industrial chemicals/specialty materials PE platform, running active roll-ups in specialty chemicals, advanced materials, industrial coatings, and pharma services. Multiples in specialty industrial chemicals typically 6-9x EBITDA at platform scale, with formulation moats and regulatory barriers (EPA registrations, REACH compliance) driving multiple expansion. Public consolidators like Ametek (NYSE: AME) and specialty chemical strategics compete in adjacent verticals.

HVAC, electrical, and industrial-services roll-ups. Public consolidators dominate industrial-services-adjacent manufacturing roll-ups. APi Group (NYSE: APG, ~$7B revenue) is one of the most active industrial-services consolidators. Comfort Systems USA (NYSE: FIX, ~$5B revenue) consolidates mechanical/electrical contractors. Watsco (NYSE: WSO, ~$7B revenue) consolidates HVAC distribution. Atkore (NYSE: ATKR) consolidates electrical infrastructure. PE platforms compete: Audax Industrial, Sterling Group, Wynnchurch Capital, AEA Investors, Genstar Capital all run industrial-services-adjacent platforms.

Niche industrial software-adjacent and IIoT roll-ups. Roper Technologies (NYSE: ROP, $6B+ revenue) has built a multi-decade roll-up of niche industrial businesses with software-margin overlay, paying 11-14x EBITDA for differentiated targets. Ametek (NYSE: AME) consolidates precision instruments and electromechanical with similar high multiples. PE platforms with digital-manufacturing theses (Audax Industrial, AEA Investors, Genstar Capital) increasingly compete in this space. Manufacturers with documented IIoT (Industrial Internet of Things) sensor deployment, MES/ERP integration, predictive maintenance, and digital factory capability draw premium multiples reflecting software-like margins layered on industrial operations.

Roll-up exit pathways and what they mean for sellers

Manufacturing PE platforms exit through three primary pathways, each with different implications for sellers who roll equity. Pathway 1: sale to mega-fund industrial vertical (KKR Industrials, Carlyle industrials, Bain Capital industrials, Onex Partners industrials, Bromford Industries) at $20M-$100M EBITDA scale and 8-12x EBITDA multiples. Pathway 2: sale to public-company strategic acquirer (APi Group, Comfort Systems USA, Watsco, Roper Technologies, HEICO, Atkore, Curtiss-Wright, TransDigm, Harsco, Ametek) often at higher multiples driven by synergy logic. Pathway 3: secondary sale to another middle-market PE platform when the platform hasn’t scaled to mega-fund or public-company size yet.

Why exit pathway matters for rollover equity holders. Sellers who roll 20-30% equity into the platform participate in the exit. Mega-fund or public-company exits typically deliver the highest multiples (8-12x vs 6-9x at middle-market secondary sale), so platforms structured to scale into mega-fund/public-strategic exit territory deliver materially better rollover returns. Sub-vertical specialists (AE Industrial Partners, Liberty Hall Capital, Linden Capital Partners, Patient Square Capital, LaSalle Capital, Arsenal Capital, Wind Point Partners) typically have clearer exit pathways to mega-fund or public consolidators because the sub-vertical specialization creates strategic logic for the eventual buyer.

Realistic rollover return scenarios. $2M EBITDA add-on rolled into a platform at 5x ($10M TEV), seller rolls 25% equity ($2.5M). Platform grows to $20M EBITDA over 4 years through organic growth + further bolt-ons. Platform exits at 8.5x ($170M TEV). Seller’s 25% rollover position (now diluted to perhaps 8-12% after additional capital raised for bolt-ons) returns approximately $13.6M-$20.4M at exit, vs original $2.5M rolled. That’s 5-8x return on the rollover portion, often producing more after-tax proceeds than the cash portion of the original sale.

Risk factors in rollover equity. Platform underperformance (EBITDA stagnation, customer loss, integration failure): rollover equity returns can be materially below modeled scenario. PE firm exit-timing optionality: GP decides when to exit, not the rollover holder. Anti-dilution and tag-along/drag-along terms: poorly negotiated rollover can result in dilution if platform raises additional equity. Rollover holders bear platform risk that wouldn’t exist with all-cash exits. Negotiate carefully or work with M&A counsel experienced in rollover terms.

Platform scaling beyond rollover holder’s exit timeline. Some PE platforms scale through multiple ownership cycles: middle-market PE acquires platform at 7x, scales to $25M EBITDA, exits at 9x to mega-fund. Mega-fund scales to $80M EBITDA, exits at 11x to public consolidator. Sellers who roll equity at the original middle-market PE acquisition can either: (1) liquidate at the first exit (still typically 5-8x return on rollover), or (2) continue rolling into the mega-fund vehicle for second-cycle participation, capturing additional 2-4x return. The decision depends on tax planning, personal liquidity needs, and confidence in the next-cycle GP.

References and further reading

Verifiable U.S. government, industry association, public-company, and PE firm sources backing the roll-up mechanics and named entities above. Multiple ranges, fund AUMs, and roll-up examples are drawn from public PE firm filings, fund-formation databases, public-company 10-K disclosures, industry trade publications, and the named firms’ investor materials. The references section at the end lists verified URLs for further research.

Conclusion

Manufacturing PE roll-ups in 2026 are economically irresistible to PE because the math works regardless of operational performance. Multiple arbitrage between 4-5x add-on cost basis and 8.5x exit multiples produces $20-40M of value creation on a $50-100M cumulative deployment, before any operational synergies. Operational synergies (capacity utilization, customer cross-sell, supply chain consolidation, equipment redundancy elimination) compound the multiple arbitrage benefit by 400-800 bps of EBITDA margin expansion. The named platforms running 2026 manufacturing roll-ups (Audax Industrial, GenNx360, Trive Capital, Sterling Group, Wynnchurch Capital, Cortec, IGP, Mason Wells, Pfingsten, AEA, Genstar, Pamlico, plus sub-vertical specialists AE Industrial Partners, Liberty Hall Capital, Linden Capital Partners, Patient Square Capital, LaSalle Capital, Arsenal Capital, Wind Point Partners, plus public consolidators APi Group, Comfort Systems USA, Watsco, Roper Technologies, HEICO, Atkore, Curtiss-Wright, TransDigm, Harsco, Ametek) have refined the playbook over multiple cycles. Sellers who understand the math negotiate platform-quality terms (6-9x EBITDA, 20-30% rollover, CEO continuity) rather than accepting add-on terms (4-6x, 10-20% rollover, integrated role); sellers who don’t, leave 1-3x EBITDA on the table. Owners who roll equity, negotiate earn-up payments tied to platform performance, secure board observer rights, and run multi-buyer processes capture meaningfully more value than those who accept the first offer. The owners who do this work see 1-3x EBITDA better outcomes than the ones who go to market unprepared. And if you want to talk to someone who already knows the roll-up buyers personally instead of accepting the first reach-out, we’re a buy-side partner — the buyers pay us, not you, no contract required.

Frequently Asked Questions

How do manufacturing PE roll-ups actually work?

PE firm buys a $5M-$30M EBITDA platform at 6-9x EBITDA. Bolts on 3-7 add-on acquisitions at $1M-$5M EBITDA each, priced at 4-6x EBITDA. Holds 3-5 years through organic growth + integration synergies. Exits at 8-9x EBITDA to a larger PE buyer (mega-fund industrial vertical) or public-company strategic. Multiple arbitrage between blended cost basis and exit multiple drives 2-3x of value creation, before any operational synergies.

What’s the difference between platform and add-on in manufacturing roll-ups?

Platforms target $5M-$30M EBITDA with documented systems, real management depth (CFO, COO), sub-vertical specialization, manageable customer concentration. Platform multiples: 6-9x. Rollover: 20-30%. CEO continues. Add-ons target $1M-$5M EBITDA with customer/capability/geography fit to the platform. Add-on multiples: 4-6x. Rollover: 10-20%. Founder typically transitions in 6-18 months. Same buyer firm, materially different terms based on which role you fit.

What’s multiple arbitrage and how does it work in roll-ups?

PE buys a platform at 7x EBITDA + add-ons at 5x EBITDA = blended cost basis around 5.9x. After 3-5 years, exits at 8-9x EBITDA. Difference between blended cost basis and exit multiple = multiple arbitrage. On a $11M EBITDA roll-up bought at 5.9x ($65M) and exited at 8.5x ($93.5M), multiple arbitrage alone creates $28.5M of value before any EBITDA growth or operational synergies.

What manufacturing-specific synergies do roll-ups create?

Capacity utilization (push 60-85% utilization to 85-95% via overflow routing): +200-400 bps EBITDA margin. Customer cross-sell (sell platform capabilities to add-on customers and vice versa): +8-15% organic revenue. Supply chain consolidation (combined raw material purchasing): +100-300 bps margin. Equipment redundancy elimination (sell underused machines, consolidate facilities): +50-150 bps margin + one-time cash. Centralized engineering, quality, ERP, sales, and overhead consolidation add another 400-800 bps cumulatively.

Which PE firms run manufacturing roll-ups in 2026?

Generalist industrial: Audax Industrial (~$43B AUM), Genstar Capital ($50B+), AEA Investors ($18B+), Trive Capital, Sterling Group, Wynnchurch Capital, Cortec Group, GenNx360, IGP, Mason Wells, Pfingsten Partners, Pamlico Capital. Sub-vertical specialists: AE Industrial Partners (aerospace, ~$5B), Liberty Hall Capital (aerospace), Linden Capital Partners (medical device, $8B+), Patient Square Capital (~$10B), LaSalle Capital (medical device), Arsenal Capital ($8B+, industrial chemicals), Wind Point Partners ($3B+). Public consolidators: APi Group (NYSE: APG), Comfort Systems USA (NYSE: FIX), Watsco (NYSE: WSO), Roper Technologies (NYSE: ROP), HEICO (NYSE: HEI), Atkore (NYSE: ATKR), Curtiss-Wright (NYSE: CW), TransDigm (NYSE: TDG), Harsco (NYSE: HSC), Ametek (NYSE: AME). Mega-fund: KKR Industrials, Carlyle industrials, Bain Capital industrials, Onex Partners industrials, Bromford Industries.

What are the most common manufacturing roll-up failure modes?

Cultural integration (30-40% of failed integrations) — family-owned add-ons resist platform standardization. Equipment redundancy and capex consolidation (15-25%) — redundant CNC/fab/molding equipment requires careful customer-program transition. Customer concentration overlap (10-15%) — platform and add-on share top customers creating portfolio concentration. Workforce integration (10-15%) — union vs non-union, different benefit structures. Failed certification audits post-integration (5-10%) — AS9100/ISO 13485/NADCAP/FDA certifications fail after add-on integration.

How can sellers capture more value from a roll-up exit?

Five tactics: (1) Roll 20-30% equity into the platform for proportional participation in multiple arbitrage and EBITDA growth at exit (typically returns 1.5-2.5x). (2) Negotiate earn-up payments tied to platform-level performance milestones, not just your business’s specific performance. (3) Secure board observer rights for visibility on platform strategy and exit planning. (4) Negotiate explicit integration commitments protecting employees and customers (retention periods, notification protocols, brand continuity). (5) Run multi-buyer process even when a specific platform reaches out, to validate market multiple.

What’s the typical timeline for a manufacturing roll-up?

Platform investment: PE firm acquires platform business over 90-180 days. Months 1-3: governance, communication, quick-win synergies. Months 4-12: ERP/MES consolidation, quality systems unification, organizational consolidation. Months 12-24: synergy realization (capacity utilization, customer cross-sell, supply chain). Months 24-48: continued add-on acquisitions, organic growth investment, exit prep. Total platform hold: 3-5 years typically. Exit to mega-fund industrial vertical or public-company consolidator at 8-9x EBITDA.

How does the math change for sub-vertical specialty roll-ups?

Sub-vertical specialists (AE Industrial Partners aerospace, Liberty Hall Capital aerospace, Linden Capital Partners medical device, Patient Square Capital medical device, LaSalle Capital medical device, Arsenal Capital industrial chemicals) pay 1-3x EBITDA more than generalists at platform investment (7-12x vs 6-9x) and exit at 9-12x vs 8-9x. The wider arbitrage spread reflects deeper operating expertise, customer-base relevance, and competitive moats from sub-vertical specialization. Sub-vertical roll-ups also tend to scale to higher exit EBITDA ($50M+ vs $20-40M generalist).

Should I roll equity into a manufacturing PE platform?

Usually yes, if the rollover percentage and terms are acceptable. Rolling 20-30% equity gives you proportional participation in multiple arbitrage, EBITDA growth, and operational synergies that drive PE returns. Sellers who roll often realize 1.5-2.5x of additional after-tax proceeds at platform exit in 3-5 years. Negotiate carefully: anti-dilution rights, tag-along/drag-along rights, valuation methodology, vesting schedule. Don’t roll if the platform looks weakly capitalized or if you mistrust the GP’s exit pathway.

Why are public-company consolidators competing with PE for manufacturing roll-ups?

Public consolidators (APi Group, Comfort Systems USA, Watsco, Roper Technologies, HEICO, Atkore, Curtiss-Wright, TransDigm, Harsco, Ametek) underwrite synergy-adjusted EBITDA against their existing platform infrastructure. They can pay 1-2x EBITDA more than PE because: (1) capacity utilization synergies, (2) customer cross-sell at scale, (3) supply chain consolidation at corporate level, (4) elimination of duplicative SG&A. The competitive bidding between PE and public strategics creates seller-favorable dynamics in 2026 manufacturing M&A.

What multiple arbitrage spread is realistic in 2026 manufacturing roll-ups?

Generalist industrial roll-ups: blended cost basis 5.5-6.5x EBITDA, exit at 8-9x EBITDA = 1.5-3.5x EBITDA spread. Sub-vertical specialty roll-ups (aerospace, medical device, industrial chemicals): blended cost basis 6-7.5x, exit at 9-12x = 2-5x spread. Mega-fund platform-of-platform roll-ups: cost basis 8-9x, exit at 10-12x = 1-3x spread but on much larger EBITDA base. Multiple arbitrage typically delivers 1.5-2.5x MOIC standalone before any EBITDA growth contribution.

How is CT Acquisitions different from a sell-side broker or M&A advisor?

We’re a buy-side partner, not a sell-side broker. Sell-side brokers represent you and charge you 8-12% of the deal (often $300K-$1M+) plus monthly retainers, run a 9-12 month auction process, and require 12-month exclusivity. We work directly with 76+ buyers — 38 of them with active manufacturing/industrial mandates running roll-ups, including the named platforms, sub-vertical specialists, public consolidators, and mega-fund industrial verticals covered in this guide — who pay us when a deal closes. You pay nothing. We move faster (60-180 days from intro to close) because we already know which platforms fit your manufacturing business as platform-quality or add-on-quality target rather than running a generic auction.

Sources & References

All claims and figures in this analysis are sourced from the publicly available references below.

1. U.S. Small Business Administration SOP 50 10 7 — Governs SBA 7(a) and 504 loan programs that fund some manufacturing add-on acquisitions, particularly in sub-LMM roll-up contexts.
2. National Association of Manufacturers (NAM) — Trade association representing 13,000+ U.S. manufacturers; publishes Manufacturing Outlook Survey documenting reshoring trends, capex intentions, and ownership demographic data relevant to roll-up supply.
3. Institute for Supply Management Manufacturing PMI — Monthly Manufacturing PMI tracking demand conditions; primary leading indicator informing roll-up timing and platform thesis.
4. APi Group (NYSE: APG) Investor Relations — Public-company filings disclosing acquisition strategy, integration playbook, and segment-level financial performance for one of the largest U.S. industrial-services consolidators.
5. HEICO Corporation (NYSE: HEI) Investor Relations — Public-company filings for the most active U.S. aerospace/defense parts consolidator; disclosure of acquisition strategy, multi-decade roll-up track record, and integration approach.
6. Roper Technologies (NYSE: ROP) Investor Relations — Public-company filings disclosing M&A approach for niche industrial-software-adjacent acquisitions; multi-decade roll-up of niche industrial businesses.
7. Watsco (NYSE: WSO) Investor Relations — Public-company filings for the largest HVAC distribution consolidator in North America; disclosure of M&A strategy and integration approach.
8. Audax Group — Industrial-focused PE firm with $43B+ AUM running active manufacturing roll-ups; publishes portfolio company list and sector strategy.
9. AE Industrial Partners — Aerospace and defense-focused PE firm running active sub-vertical specialty roll-ups; publishes portfolio across aerospace, defense, space, and government services manufacturing.
10. Linden Capital Partners — Healthcare and medical-device-focused middle-market PE firm running active medical-device manufacturing roll-ups.
11. Bureau of Economic Analysis — Industry GDP — Manufacturing share of U.S. GDP and value-added output by sub-sector; informs roll-up sub-vertical sizing.
12. National Tooling and Machining Association (NTMA) — Industry association for U.S. tool and die, mold, and machining manufacturers; documents owner demographic data driving roll-up supply.